{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T02:49:48Z","timestamp":1783478988414,"version":"3.55.0"},"reference-count":27,"publisher":"The Endocrine Society","issue":"1","funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["ZIA DK074084-08"],"award-info":[{"award-number":["ZIA DK074084-08"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>The effects of leptin, an adipocyte-derived hormone that signals overall energy sufficiency, can only be studied in leptin-deficient conditions. In patients with lipodystrophy, a rare disease and unique model of leptin deficiency, treatment with recombinant leptin (metreleptin) improves glycemia and decreases energy expenditure. We hypothesized that these improvements might be mediated by reduced gluconeogenesis (GNG), an energy-requiring process.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To determine the effects of metreleptin on GNG and GNG substrates.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This was a single-arm prospective study of metreleptin administration in 15 patients with lipodystrophy, 9 of whom had data on GNG (NIH, 2013-2018). We analyzed total GNG, insulin-mediated suppression of GNG, glycerol, palmitate, alanine, lactate, peripheral and hepatic insulin sensitivity, and markers of glycemia (eg, HbA1c, glucose, fasting insulin).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Metreleptin administration decreased basal GNG, increased insulin-mediated suppression of GNG, and improved insulin sensitivity and markers of glycemic control. Metreleptin reduced carbon sources for GNG, including plasma alanine and lactate, and rate of appearance (Ra) of glycerol, and decreased Ra of palmitate, a driver of GNG. Glycerol and palmitate Ra correlated with GNG prior to but not during metreleptin administration. Alanine strongly correlated with GNG both before and during metreleptin administration.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Metreleptin treatment in patients with lipodystrophy reduced GNG likely through decreased availability of carbon sources for gluconeogenesis, such as alanine, lactate, and glycerol. Associations between alanine and GNG persisted after metreleptin treatment while correlations with glycerol and palmitate Ra did not persist, suggesting reduced importance of lipolysis as a driver of GNG in the leptin-replete state.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgad445","type":"journal-article","created":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T20:31:41Z","timestamp":1690489901000},"page":"e209-e215","source":"Crossref","is-referenced-by-count":6,"title":["Leptin Decreases Gluconeogenesis and Gluconeogenic Substrate Availability in Patients With Lipodystrophy"],"prefix":"10.1210","volume":"109","author":[{"given":"Emmanuel","family":"Quaye","sequence":"first","affiliation":[{"name":"National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health , Bethesda, MD 20892 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaji","family":"Chacko","sequence":"additional","affiliation":[{"name":"U.S. Department of Agriculture\/Agricultural Research Service Children's Nutrition Research Center, Department of Pediatrics, Baylor College of Medicine , Houston, TX 77030 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Startzell","sequence":"additional","affiliation":[{"name":"National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health , Bethesda, MD 20892 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2589-7382","authenticated-orcid":false,"given":"Rebecca J","family":"Brown","sequence":"additional","affiliation":[{"name":"National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health , Bethesda, MD 20892 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2023,7,29]]},"reference":[{"issue":"2","key":"2023122122181405400_dgad445-B1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0002-9343(99)00414-3","article-title":"Lipodystrophies","volume":"108","author":"Garg","year":"2000","journal-title":"Am J Med"},{"issue":"8","key":"2023122122181405400_dgad445-B2","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1172\/JCI95476","article-title":"Metreleptin-mediated improvements in insulin sensitivity are independent of food intake in humans with lipodystrophy","volume":"128","author":"Brown","year":"2018","journal-title":"J Clin Invest"},{"issue":"10","key":"2023122122181405400_dgad445-B3","doi-asserted-by":"crossref","first-page":"e4163","DOI":"10.1210\/clinem\/dgab269","article-title":"Leptin decreases energy expenditure despite increased thyroid hormone in patients with lipodystrophy","volume":"106","author":"Grover","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"14","key":"2023122122181405400_dgad445-B4","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.137180","article-title":"Leptin decreases de novo lipogenesis in patients with lipodystrophy","volume":"5","author":"Baykal","year":"2020","journal-title":"JCI Insight"},{"issue":"3","key":"2023122122181405400_dgad445-B5","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1152\/physrev.1997.77.3.731","article-title":"Cellular energy utilization and molecular origin of standard metabolic rate in mammals","volume":"77","author":"Rolfe","year":"1997","journal-title":"Physiol Rev"},{"issue":"2","key":"2023122122181405400_dgad445-B6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.cmet.2007.12.009","article-title":"Selective versus total insulin resistance: a pathogenic paradox","volume":"7","author":"Brown","year":"2008","journal-title":"Cell Metab"},{"issue":"7","key":"2023122122181405400_dgad445-B7","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1172\/JCI135431","article-title":"Free fatty acid processing diverges in human pathologic insulin resistance conditions","volume":"130","author":"Sekizkardes","year":"2020","journal-title":"J Clin Invest"},{"issue":"6","key":"2023122122181405400_dgad445-B8","doi-asserted-by":"crossref","first-page":"E795","DOI":"10.1152\/ajpendo.00281.2021","article-title":"Energy expenditure due to gluconeogenesis in pathologic conditions of insulin resistance","volume":"321","author":"Quaye","year":"2021","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"3","key":"2023122122181405400_dgad445-B9","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2337\/diabetes.55.03.06.db05-1117","article-title":"The greater contribution of gluconeogenesis to glucose production in obesity is related to increased whole-body protein catabolism","volume":"55","author":"Chevalier","year":"2006","journal-title":"Diabetes"},{"issue":"4968","key":"2023122122181405400_dgad445-B10","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1126\/science.2166335","article-title":"Identification of a sequence in the PEPCK gene that mediates a negative effect of insulin on transcription","volume":"249","author":"O'Brien","year":"1990","journal-title":"Science"},{"issue":"18","key":"2023122122181405400_dgad445-B11","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1128\/MCB.01584-12","article-title":"Insulin inhibits lipolysis in adipocytes via the evolutionarily conserved mTORC1-Egr1-ATGL-mediated pathway","volume":"33","author":"Chakrabarti","year":"2013","journal-title":"Mol Cell Biol"},{"issue":"3920","key":"2023122122181405400_dgad445-B12","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1126\/science.167.3920.1003","article-title":"Alanine: key role in gluconeogenesis","volume":"167","author":"Felig","year":"1970","journal-title":"Science"},{"issue":"7","key":"2023122122181405400_dgad445-B13","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s42255-020-0243-4","article-title":"Lactate: the ugly duckling of energy metabolism","volume":"2","author":"Rabinowitz","year":"2020","journal-title":"Nat Metab"},{"issue":"4","key":"2023122122181405400_dgad445-B14","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"2023122122181405400_dgad445-B15","volume-title":"Isotope Tracers in Metabolic Research: Principles and Practice of Kinetic Analysis","author":"Wolfe","year":"2004"},{"issue":"4","key":"2023122122181405400_dgad445-B16","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1152\/japplphysiol.00752.2007","article-title":"Measurement of gluconeogenesis using glucose fragments and mass spectrometry after ingestion of deuterium oxide","volume":"104","author":"Chacko","year":"2008","journal-title":"J Appl Physiol (1985)"},{"issue":"8","key":"2023122122181405400_dgad445-B17","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1210\/js.2019-00103","article-title":"Advanced lipoprotein analysis shows atherogenic lipid profile that improves after metreleptin in patients with lipodystrophy","volume":"3","author":"Kinzer","year":"2019","journal-title":"J Endocr Soc"},{"key":"2023122122181405400_dgad445-B18","first-page":"1","article-title":"Plasma total amino acids, plasma glutamate and alanine levels in diabetic subjects","volume":"14","author":"Kashinath","year":"2014","journal-title":"Glob J Med Res"},{"issue":"6939","key":"2023122122181405400_dgad445-B19","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nature01667","article-title":"Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction","volume":"423","author":"Puigserver","year":"2003","journal-title":"Nature"},{"issue":"7111","key":"2023122122181405400_dgad445-B20","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1038\/nature05288","article-title":"Gluconeogenesis: re-evaluating the FOXO1-PGC-1alpha connection","volume":"443","author":"Schilling","year":"2006","journal-title":"Nature"},{"issue":"7219","key":"2023122122181405400_dgad445-B21","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nature07349","article-title":"A fasting inducible switch modulates gluconeogenesis via activator\/coactivator exchange","volume":"456","author":"Liu","year":"2008","journal-title":"Nature"},{"issue":"4","key":"2023122122181405400_dgad445-B22","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","article-title":"Mechanisms of insulin action and insulin resistance","volume":"98","author":"Petersen","year":"2018","journal-title":"Physiol Rev"},{"issue":"9","key":"2023122122181405400_dgad445-B23","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1172\/JCI200112876","article-title":"The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression","volume":"108","author":"Nakae","year":"2001","journal-title":"J Clin Invest"},{"key":"2023122122181405400_dgad445-B24","doi-asserted-by":"crossref","first-page":"7079","DOI":"10.1038\/ncomms8079","article-title":"Foxo1 integrates direct and indirect effects of insulin on hepatic glucose production and glucose utilization","volume":"6","author":"O-Sullivan","year":"2015","journal-title":"Nat Commun"},{"issue":"1","key":"2023122122181405400_dgad445-B25","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/cphy.c130024","article-title":"Energy metabolism in the liver","volume":"4","author":"Rui","year":"2014","journal-title":"Compr Physiol"},{"issue":"7","key":"2023122122181405400_dgad445-B26","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s001250050745","article-title":"Renal glucose production and utilization: new aspects in humans","volume":"40","author":"Stumvoll","year":"1997","journal-title":"Diabetologia"},{"issue":"2 Pt 1","key":"2023122122181405400_dgad445-B27","first-page":"E314","article-title":"Impact of chronic stress hormone infusion on hepatic carbohydrate metabolism in the conscious dog","volume":"265","author":"McGuinness","year":"1993","journal-title":"Am J Physiol"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgad445\/51037539\/dgad445.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/109\/1\/e209\/54731318\/dgad445.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/109\/1\/e209\/54731318\/dgad445.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T22:19:20Z","timestamp":1703197160000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/109\/1\/e209\/7233593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,29]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,7,29]]},"published-print":{"date-parts":[[2023,12,21]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgad445","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,1]]},"published":{"date-parts":[[2023,7,29]]}}}